Liliana Montella - Concepedia

Author

Liliana Montella

Nuovo Ospedale San Giovanni di Dio ORCID

Also Known As

L Montella, L. MONTELLA, L. Montella, LILIANA MONTELLA, Liliana Montella, Montella, Liliana, R. Addeo

138

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Nuovo Ospedale San Giovanni di Dio University of Naples Federico II University of Campania "Luigi Vanvitelli"Federico II University Hospital Università Campus Bio-Medico

About

Liliana Montella is an author at Nuovo Ospedale San Giovanni di Dio specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	21	754
2	Education	1	1	16
3	Public Health	1	1	16
4	Allergy	1	1	12
5	Cell Biology	1	1	97

Liliana Montella

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Randomized Phase III Trial on Gemcitabine Versus Mytomicin in Recurrent Superficial Bladder Cancer: Evaluation of Efficacy and Tolerance Raffaele Addeo, Michele Caraglia, Sergio Bellini, Journal of Clinical Oncology	2009	188
Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib Bruno Vincenzi, Daniele Santini, Antonio Russo, The Oncologist	2010	174
Somatostatin analogs and prednisone in advanced refractory thymic tumors Giovannella Palmieri, Liliana Montella, Angelo Martignetti, Cancer	2002	102
Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR Michele Caraglia, G. Giuberti, Maurizio Marra, Cell Death and Disease Octreotide LarHepatologyHepatocellular Carcinoma PatientsHepatocellular CarcinomaMedicine	2011	97
Low-Dose Metronomic Oral Administration of Vinorelbine in the First-line Treatment of Elderly Patients With Metastatic Breast Cancer Raffaele Addeo, Alessandro Sgambato, Gregorio Cennamo, Clinical Breast Cancer Metastatic Breast CancerOncologyElderly PatientsMedicineMetronomic Therapy	2010	92
Phase 2 trial of temozolomide using protracted low‐dose and whole‐brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases Raffaele Addeo, Carmine De Rosa, Vincenzo Faiola, Cancer	2008	91
Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study Salvatore Del Prete, Liliana Montella, Michele Caraglia, Cancer Chemotherapy and Pharmacology HepatologyMedicineSafe TreatmentPharmacologyPathology	2009	78
Concomitant treatment of brain metastasis with Whole Brain Radiotherapy [WBRT] and Temozolomide [TMZ] is active and improves Quality of Life Raffaele Addeo, Michele Caraglia, Vincenzo Faiola, BMC Cancer	2007	76
A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma Raffaele Addeo, Michele Caraglia, M. Serena De Santi, Journal of Neuro-Oncology	2010	69
Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours Michele Caraglia, Raffaele Addeo, Raffaele Costanzo, Cancer Chemotherapy and Pharmacology Neuro-oncologyPegylated Liposomal DoxorubicinOncologyMedicineSolid Tumours	2005	67

Page 1